These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23613427)

  • 1. Perlman syndrome: overgrowth, Wilms tumor predisposition and DIS3L2.
    Morris MR; Astuti D; Maher ER
    Am J Med Genet C Semin Med Genet; 2013 May; 163C(2):106-13. PubMed ID: 23613427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility.
    Astuti D; Morris MR; Cooper WN; Staals RH; Wake NC; Fews GA; Gill H; Gentle D; Shuib S; Ricketts CJ; Cole T; van Essen AJ; van Lingen RA; Neri G; Opitz JM; Rump P; Stolte-Dijkstra I; Müller F; Pruijn GJ; Latif F; Maher ER
    Nat Genet; 2012 Feb; 44(3):277-84. PubMed ID: 22306653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term survival of a patient with Perlman syndrome due to novel compound heterozygous missense mutations in RNB domain of DIS3L2.
    Soma N; Higashimoto K; Imamura M; Saitoh A; Soejima H; Nagasaki K
    Am J Med Genet A; 2017 Apr; 173(4):1077-1081. PubMed ID: 28328139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of
    Hunter RW; Liu Y; Manjunath H; Acharya A; Jones BT; Zhang H; Chen B; Ramalingam H; Hammer RE; Xie Y; Richardson JA; Rakheja D; Carroll TJ; Mendell JT
    Genes Dev; 2018 Jul; 32(13-14):903-908. PubMed ID: 29950491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DIS3L2 Gene Mutation Causes the Perlman Syndrome of Overgrowth and Wilms Tumor Susceptibility.
    Al Ghadeer HA; Alghazal FA; Alessa MA; Alghafli JA; Alkhalaf GI; Bumejdad HN; Alherz RM; Alshaikh Saleh RA; Almumtin KA; Abu Sinah AK
    Cureus; 2023 Dec; 15(12):e49777. PubMed ID: 38161545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perlman syndrome: report, prenatal findings and review.
    Alessandri JL; Cuillier F; Ramful D; Ernould S; Robin S; de Napoli-Cocci S; Rivière JP; Rossignol S
    Am J Med Genet A; 2008 Oct; 146A(19):2532-7. PubMed ID: 18780370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Perlman syndrome research progress].
    Wang Z; Liu J; Yang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Oct; 38(10):1021-1024. PubMed ID: 34625946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homozygous deletion of DIS3L2 exon 9 due to non-allelic homologous recombination between LINE-1s in a Japanese patient with Perlman syndrome.
    Higashimoto K; Maeda T; Okada J; Ohtsuka Y; Sasaki K; Hirose A; Nomiyama M; Takayanagi T; Fukuzawa R; Yatsuki H; Koide K; Nishioka K; Joh K; Watanabe Y; Yoshiura K; Soejima H
    Eur J Hum Genet; 2013 Nov; 21(11):1316-9. PubMed ID: 23486540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs.
    Łabno A; Warkocki Z; Kuliński T; Krawczyk PS; Bijata K; Tomecki R; Dziembowski A
    Nucleic Acids Res; 2016 Dec; 44(21):10437-10453. PubMed ID: 27431325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for the Perlman syndrome exonuclease Dis3l2 in the Lin28-let-7 pathway.
    Chang HM; Triboulet R; Thornton JE; Gregory RI
    Nature; 2013 May; 497(7448):244-8. PubMed ID: 23594738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overgrowth syndromes and pediatric cancers: how many roads lead to
    Bharathavikru R; Hastie ND
    Genes Dev; 2018 Aug; 32(15-16):993-995. PubMed ID: 30068702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Perlman syndrome DIS3L2 exoribonuclease safeguards endoplasmic reticulum-targeted mRNA translation and calcium ion homeostasis.
    Pirouz M; Wang CH; Liu Q; Ebrahimi AG; Shamsi F; Tseng YH; Gregory RI
    Nat Commun; 2020 May; 11(1):2619. PubMed ID: 32457326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare clinical entity Perlman syndrome: is cholestasis a new finding?
    Demirel G; Oguz SS; Celik IH; Uras N; Erdeve O; Dilmen U
    Congenit Anom (Kyoto); 2011 Mar; 51(1):43-5. PubMed ID: 20726997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical features and genetic analysis of a case with Perlman syndrome due to variant of DIS3L2 gene].
    Chen J; Hu C; Ren L; Li J; Lei T; Chen S; Zhao P
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Jan; 39(1):48-51. PubMed ID: 34964966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Perlman syndrome: familial renal dysplasia with Wilms tumor, fetal gigantism and multiple congenital anomalies. 1984.
    Neri G; Martini-Neri ME; Katz BE; Opitz JM
    Am J Med Genet A; 2013 Nov; 161A(11):2691-6. PubMed ID: 24166810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perlman syndrome: four additional cases and review.
    Henneveld HT; van Lingen RA; Hamel BC; Stolte-Dijkstra I; van Essen AJ
    Am J Med Genet; 1999 Oct; 86(5):439-46. PubMed ID: 10508986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Report: 2-Year-old With Wilms Tumors, Familial Heterozygous DIS3L2 Mutation, and Cutis Marmorata Telangiectatica Congenita.
    Friedman CD; DeBrosse S; Mitchell A; Horn J; Merrill M
    J Pediatr Hematol Oncol; 2023 Jan; 45(1):e128-e130. PubMed ID: 35700413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Perlman familial nephroblastomatosis syndrome.
    Greenberg F; Stein F; Gresik MV; Finegold MJ; Carpenter RJ; Riccardi VM; Beaudet AL
    Am J Med Genet; 1986 May; 24(1):101-10. PubMed ID: 3010722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wilms' tumor in patients with 9q22.3 microdeletion syndrome suggests a role for PTCH1 in nephroblastomas.
    Isidor B; Bourdeaut F; Lafon D; Plessis G; Lacaze E; Kannengiesser C; Rossignol S; Pichon O; Briand A; Martin-Coignard D; Piccione M; David A; Delattre O; Jeanpierre C; Sévenet N; Le Caignec C
    Eur J Hum Genet; 2013 Jul; 21(7):784-7. PubMed ID: 23169491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of Perlman syndrome presenting with hemorrhagic hemangioma.
    Pirgon O; Atabek ME; Akin F; Sert A
    J Pediatr Hematol Oncol; 2006 Aug; 28(8):531-3. PubMed ID: 16912594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.